ScholarIQanswers from OpenAlex

Impact of orthokeratology and low‐dose atropine on corneal biomechanics and myopia progression in children

PaperCitations, authors & open-access status

Impact of orthokeratology and low‐dose atropine on corneal biomechanics and myopia progression in children is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Impact of orthokeratology and low‐dose atropine on corneal biomechanics and myopia progression in children have?

ScholarIQcitation count

Impact of orthokeratology and low‐dose atropine on corneal biomechanics and myopia progression in children has 5 citations in the OpenAlex counts ScholarIQ stores.

When was Impact of orthokeratology and low‐dose atropine on corneal biomechanics and myopia progression in children published?

ScholarIQyear

Impact of orthokeratology and low‐dose atropine on corneal biomechanics and myopia progression in children has 2025 year in the ScholarIQ index.

What is the open-access status of Impact of orthokeratology and low‐dose atropine on corneal biomechanics and myopia progression in children?

ScholarIQoa status

Impact of orthokeratology and low‐dose atropine on corneal biomechanics and myopia progression in children has closed oa status in the ScholarIQ index.

What is the DOI of Impact of orthokeratology and low‐dose atropine on corneal biomechanics and myopia progression in children?

ScholarIQdoi

The DOI for Impact of orthokeratology and low‐dose atropine on corneal biomechanics and myopia progression in children is on the source record.

What is the PMID of Impact of orthokeratology and low‐dose atropine on corneal biomechanics and myopia progression in children?

ScholarIQpmid

The PMID for Impact of orthokeratology and low‐dose atropine on corneal biomechanics and myopia progression in children is on the source record.

What is the OpenAlex record for Impact of orthokeratology and low‐dose atropine on corneal biomechanics and myopia progression in children?

ScholarIQopenalex

The OpenAlex for Impact of orthokeratology and low‐dose atropine on corneal biomechanics and myopia progression in children is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial